Cargando…
Engineered off-the-shelf therapeutic T cells resist host immune rejection
Autores principales: | Mo, Feiyan, Watanabe, Norihiro, McKenna, Mary K, Hicks, M. John, Srinivasan, Madhuwanti, Gomes-Silva, Diogo, Atilla, Erden, Smith, Tyler, Atilla, Pinar Ataca, Ma, Royce, Quach, David, Heslop, Helen E., Brenner, Malcolm K., Mamonkin, Maksim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854790/ https://www.ncbi.nlm.nih.gov/pubmed/32661440 http://dx.doi.org/10.1038/s41587-020-0601-5 |
Ejemplares similares
-
Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia
por: Ataca Atilla, Pinar, et al.
Publicado: (2020) -
Resistance against anti-CD19 and anti-BCMA CAR T cells: Recent advances and coping strategies
por: Atilla, Pinar Ataca, et al.
Publicado: (2022) -
A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations
por: Atilla, Erden, et al.
Publicado: (2017) -
New Orders to an Old Soldier: Optimizing NK Cells for Adoptive Immunotherapy in Hematology
por: Gunduz, Mehmet, et al.
Publicado: (2021) -
Hepatitis B Reactivation Rate and Fate Among Multiple Myeloma Patients Receiving Regimens Containing Lenalidomide and/or Bortezomib
por: Ataca Atilla, Pınar, et al.
Publicado: (2019)